NUCLIDIUM
Series BZurich, SwitzerlandMay 2026
NUCLIDIUM raised €29M in a Series B round in May 2026. The company is based in Zurich, Switzerland. Investors in the round: Angelini Ventures, Aurea, Bayern Kapital and 5 others. Data as of 4 Nov 2026.
Amount raised
€29M
€28,536,933
Native amount
26,000,000 CHF
Stage
Series B
series b
Investors
8
Provenance & confidence
High confidenceAmount
26,000,000 CHF
ECB-at-date → €29M · rate 0.9111 on 2026-05-29
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
8 namedAngelini VenturesAureaBayern KapitalKurma Growth Opportunities FundNeva SGRNRW.BANKVIVES PartnersWellington Partners
Date
May 2026
Round type
series b
Amount (EUR)
€29M